These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 17521226)

  • 1. Assessing the role of drugs in suicidal ideation and suicidality.
    Reith DM; Edmonds L
    CNS Drugs; 2007; 21(6):463-72. PubMed ID: 17521226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [SSRIs (selective serotonin reuptake inhibitors) and suicidality in adults, adolescents and children].
    Tandt H; Audenaert K; van Heeringen C
    Tijdschr Psychiatr; 2009; 51(6):387-93. PubMed ID: 19517368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.
    Hetrick S; Merry S; McKenzie J; Sindahl P; Proctor M
    Cochrane Database Syst Rev; 2007 Jul; (3):CD004851. PubMed ID: 17636776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suicidality and aggression during antidepressant treatment: systematic review and meta-analyses based on clinical study reports.
    Sharma T; Guski LS; Freund N; Gøtzsche PC
    BMJ; 2016 Jan; 352():i65. PubMed ID: 26819231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a brief report.
    Meyer RE; Salzman C; Youngstrom EA; Clayton PJ; Goodwin FK; Mann JJ; Alphs LD; Broich K; Goodman WK; Greden JF; Meltzer HY; Normand SL; Posner K; Shaffer D; Oquendo MA; Stanley B; Trivedi MH; Turecki G; Beasley CM; Beautrais AL; Bridge JA; Brown GK; Revicki DA; Ryan ND; Sheehan DV
    J Clin Psychiatry; 2010 Aug; 71(8):1040-6. PubMed ID: 20673551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between antidepressant half-life and the risk of suicidal ideation or behavior among children and adolescents: confirmatory analysis and research implications.
    Smith EG
    J Affect Disord; 2009 Apr; 114(1-3):143-8. PubMed ID: 18692250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review.
    Gunnell D; Saperia J; Ashby D
    BMJ; 2005 Feb; 330(7488):385. PubMed ID: 15718537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suicide prevention and serotonergic drugs.
    Montgomery SA
    Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():83-5. PubMed ID: 8201249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a consensus statement.
    Meyer RE; Salzman C; Youngstrom EA; Clayton PJ; Goodwin FK; Mann JJ; Alphs LD; Broich K; Goodman WK; Greden JF; Meltzer HY; Normand SL; Posner K; Shaffer D; Oquendo MA; Stanley B; Trivedi MH; Turecki G; Beasley CM; Beautrais AL; Bridge JA; Brown GK; Revicki DA; Ryan ND; Sheehan DV
    J Clin Psychiatry; 2010 Aug; 71(8):e1-e21. PubMed ID: 20797373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suicidality in pediatric patients treated with antidepressant drugs.
    Hammad TA; Laughren T; Racoosin J
    Arch Gen Psychiatry; 2006 Mar; 63(3):332-9. PubMed ID: 16520440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The controversial link between antidepressants and suicidality risks in adults: data from a naturalistic study on a large sample of in-patients with a major depressive episode.
    Seemüller F; Riedel M; Obermeier M; Bauer M; Adli M; Mundt C; Holsboer F; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Jäger M; Henkel V; Möller HJ
    Int J Neuropsychopharmacol; 2009 Mar; 12(2):181-9. PubMed ID: 18662490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between suicidality and treatment with selective serotonin reuptake inhibitors in older people with major depression: a systematic review.
    KoKoAung E; Cavenett S; McArthur A; Aromataris E
    JBI Database System Rev Implement Rep; 2015 Apr; 13(3):174-205. PubMed ID: 26447056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration.
    Stone M; Laughren T; Jones ML; Levenson M; Holland PC; Hughes A; Hammad TA; Temple R; Rochester G
    BMJ; 2009 Aug; 339():b2880. PubMed ID: 19671933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suicidal risk from TADS study was higher than it first appeared.
    Högberg G; Antonuccio DO; Healy D
    Int J Risk Saf Med; 2015; 27(2):85-91. PubMed ID: 26410011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there evidence for negative effects of antidepressants on suicidality in depressive patients? A systematic review.
    Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2006 Dec; 256(8):476-96. PubMed ID: 17143567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suicide behaviour of patients treated with antidepressants.
    Rihmer Z; Gonda X
    Neuropsychopharmacol Hung; 2006 Mar; 8(1):13-6. PubMed ID: 16841560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressants and suicidality: the basis of controversies.
    Marcinko D
    Psychiatr Danub; 2007 Sep; 19(3):238-40. PubMed ID: 17914327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suicidal risk during controlled clinical investigations of fluvoxamine.
    Letizia C; Kapik B; Flanders WD
    J Clin Psychiatry; 1996 Sep; 57(9):415-21. PubMed ID: 9746450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Psychopharmaceuticals for treatment of suicidal patients and for suicide prevention].
    Haußmann R; Bauer M; Lewitzka U; Müller-Oerlinghausen B
    Nervenarzt; 2016 May; 87(5):483-7. PubMed ID: 26952239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants.
    Posner K; Oquendo MA; Gould M; Stanley B; Davies M
    Am J Psychiatry; 2007 Jul; 164(7):1035-43. PubMed ID: 17606655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.